Iron Nanoparticles for Low-Power Local Magnetic Hyperthermia in Combination with Immune Checkpoint Blockade for Systemic Antitumor Therapy

Abstract

Magnetic hyperthermia (MHT) utilizing heat generated by magnetic nanoparticles under alternating magnetic field (AMF) is an effective local tumor ablation method but can hardly treat metastatic tumors. In this work, we discover that pure iron nanoparticles (FeNPs) with high magnetic saturation intensity after being modified by biocompatible polymers are stable in aqueous solution and could be employed as a supereffective MHT agent to generate sufficient heating under a low-power AFM. Effective MHT ablation of tumors is then achieved, using either locally injected FeNPs or intravenously injected FeNPs with the help of locally applied tumor-focused constant magnetic field to enhance the tumor accumulation of those nanoparticles. We further demonstrate that the combination of FeNP-based MHT with local injection of nanoadjuvant and systemic injection of anticytotoxic T-lymphocyte antigen-4 (anti-CTLA4) checkpoint blockade would result in systemic therapeutic responses to inhibit tumor metastasis. A robust immune memory effect to prevent tumor recurrence is also observed after the combined MHT-immunotherapy. This work not only highlights that FeNPs with appropriate surface modification could act as a supereffective MHT agent but also presents the great promises of combining MHT with immunotherapy to achieve long-lasting systemic therapeutic outcome after local treatment.

A Multifunctional Cascade Bioreactor Based on Hollow‐Structured Cu2MoS4 for Synergetic Cancer Chemo‐Dynamic Therapy/Starvation Therapy/Phototherapy/Immunotherapy with Remarkably Enhanced Efficacy

“…However, almost 90% of cancer‐related death is due to metastasis rather than primary tumor growth . In recent years, cancer immunotherapy by stimulating the inherent immunological systems of the patients has shown tremendous prospect for inhibiting metastasized cancer . It is now established that radio‐, photo‐, and chemotherapy could cause cancer cell death in the primary lesion and induce dying tumor cells to release tumor‐associated antigens (TAAs) .…”

Triangle-Shaped Tellurium Nanostars Potentiate Radiotherapy by Boosting Checkpoint Blockade Immunotherapy

“…Flow-Cytometry Analysis of T Lymphocytes and Macrophages in Primary Tumor and Spleen After 33 days, single-tumor and spleen cell suspensions were collected according to previously reported methods. [71][72][73] These cell suspensions were then cultured with anti-CD16/32 (catalog #101320) to block nonspecific binding to FcRs. Thereafter, various fluorochrome-conjugated antibodies such as CD3 (#100204), CD4 (#100559), CD8 (#100722), CD11c (#117343), MHC-II (#107626), F4/80 (#123146), and CD206 (#141721) were added to stain these cells according to the vendors' protocols.…”

Hyperthermia and immunotherapy: clinical opportunities

“…Preclinical studies have demonstrated significant variations in how specific responses are elicited or augmented with heat. For instance, higher temperatures applied over a brief period may be best to augment CPI therapy [25] while trafficking of T cells to tumor may benefit from mild hyperthermia applied over a longer period of time [11]. Therefore, temperature gradients across a heated tumor may be helpful in eliciting wide ranging immunotherapeutic responses due to different dose profiles being associated with differing immune effects.…”